TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30102174

Group type: EXPERIMENTAL
Intervention: Peer support intervention with up to ten sessions with a peer support worker who assisted in completing a personal recovery workbook.
Number of subjects: 441

Group type: COMPARATOR
Intervention: Control group received the personal recovery workbook by post.
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Peer support intervention
Number of subjects: 441

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 441
Study: 26732142

Group type: EXPERIMENTAL
Intervention: Nebulized hypertonic saline (3 mL, 4 times/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (0.9% saline, 3 mL, 4 times/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nebulized hypertonic saline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 24508581

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy (CBT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 60
Study: 22397454

Group type: EXPERIMENTAL
Intervention: 1 × week training (80% of maximum)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 2 × week training (80% and 50%)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 72
Study: 20230419

Group type: EXPERIMENTAL
Intervention: Romiplostim
Number of subjects: 125

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 125
Study: 17433898

Group type: EXPERIMENTAL
Intervention: Vitamin supplementation (folic acid, pyridoxine, vitamin B12)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 15713727

Group type: EXPERIMENTAL
Intervention: 125 IU hCG
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 250 IU hCG
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: 500 IU hCG
Number of subjects: 29

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 29
Study: 12390102

Group type: EXPERIMENTAL
Intervention: RAC (Rabeprazole + Amoxicillin + Clarithromycin)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: R20C400 (Rabeprazole 10 mg + Amoxicillin 750 mg + Clarithromycin 200 mg, twice daily)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: R40C400 (Rabeprazole 20 mg + Amoxicillin 750 mg + Clarithromycin 200 mg, twice daily)
Number of subjects: 295

Group type: EXPERIMENTAL
Intervention: R40C800 (Rabeprazole 20 mg + Amoxicillin 750 mg + Clarithromycin 400 mg, twice daily)
Number of subjects: 295

Group type: COMPARATOR
Intervention: LAC (Lansoprazole + Amoxicillin + Clarithromycin)
Number of subjects: 295
Study: 9949744

Group type: EXPERIMENTAL
Intervention: Cash bonus for practice-wide increases
Number of subjects: 60

Group type: COMPARATOR
Intervention: Enhanced fee for service
Number of subjects: 60

Group type: COMPARATOR
Intervention: Feedback
Number of subjects: 60
Study: 8775655

Group type: EXPERIMENTAL
Intervention: Preventive services intervention (workshops and individualized counseling on nutrition and exercise)
Number of subjects: 0
Study: 1976543

Group type: EXPERIMENTAL
Intervention: Oral PGE2 tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous oxytocin
Number of subjects: 0
Study: 6988948

Group type: EXPERIMENTAL
Intervention: Preoperative tinidazole added to pre-, per-, and postoperative doxycycline
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo added to pre-, per-, and postoperative doxycycline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tinidazole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 0
Study: 31706886

Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon (DCB)
Number of subjects: 285

Group type: COMPARATOR
Intervention: Control (uncoated balloon)
Number of subjects: 285
Study: 31336497

Group type: EXPERIMENTAL
Intervention: 60 g soy nut diet for 8 weeks
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual diet of diabetes
Number of subjects: 70
Study: 28801554

Group type: EXPERIMENTAL
Intervention: Delayed fractional dose regimen of the RTS,S malaria vaccine (0-1-7 month schedule, third dose at 20% of full dose)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSP-specific IgG1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CSP-specific IgG4
Number of subjects: 0
Study: 25459687

Group type: EXPERIMENTAL
Intervention: Intracoronary transplantation of CD34(+) cells
Number of subjects: 21
Study: 25617561

Group type: EXPERIMENTAL
Intervention: Lemon verbena supplementation (10% w/w verbascoside)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 23067901

Group type: EXPERIMENTAL
Intervention: Trainee operator using transradial (TR) access
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Trainee operator using transfemoral (TF) access
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Expert operator using transradial (TR) access
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Expert operator using transfemoral (TF) access
Number of subjects: 100

Group type: COMPARATOR
Intervention: Transfemoral (TF) access
Number of subjects: 100
Study: 19579201

Group type: EXPERIMENTAL
Intervention: SprayShield™ Adhesion Barrier System
Number of subjects: 0

Group type: COMPARATOR
Intervention: Good surgical technique (Control)
Number of subjects: 0
Study: 17473089

Group type: EXPERIMENTAL
Intervention: Trimethoprim/sulfamethoxazole (18 mg/kg, 2 times per day) for 6 to 12 weeks
Number of subjects: 101

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study: 15081178

Group type: EXPERIMENTAL
Intervention: Community consultation (CC) and public disclosure (PD) activities conducted by investigators
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: IRB approval process
Number of subjects: 0
Study: 11864862

Group type: EXPERIMENTAL
Intervention: Dietary magnesium intake less than 160 mg/d (less than half of the recommended dietary allowance)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Dietary magnesium intake of 320 mg/d (recommended dietary allowance)
Number of subjects: 22
Study: 10753423

Group type: EXPERIMENTAL
Intervention: Arlevert therapy
Number of subjects: 122

Group type: COMPARATOR
Intervention: dimenhydrinate
Number of subjects: 122

Group type: COMPARATOR
Intervention: cinnarizine
Number of subjects: 122
Study: 8561101

Group type: EXPERIMENTAL
Intervention: Rapid admission (1-day)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Slow admission (14-day)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Rapid admission (1-day) and Slow admission (14-day)
Number of subjects: 186
Study: 1977626

Group type: EXPERIMENTAL
Intervention: Elective hospitalization between 30-32 and 36 weeks of gestation
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group 1: Not hospitalized, instructed to rest at home
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group 2: Not hospitalized, not instructed to rest at home
Number of subjects: 151
Study: 31588657

Group type: EXPERIMENTAL
Intervention: Rongliflozin (10-50 mg once daily for 12 days in T2DM)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rongliflozin (10-200 mg single ascending dose in healthy participants)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Rongliflozin (20 mg with food in healthy participants)
Number of subjects: 86
Study: 29406435

Group type: EXPERIMENTAL
Intervention: NIT-NASHs test
Number of subjects: 1081

Group type: COMPARATOR
Intervention: NIT-NASHs test in control group
Number of subjects: 1081

Group type: COMPARATOR
Intervention: NIT-NASHs test vs standard tests
Number of subjects: 1081

Group type: EXPERIMENTAL
Intervention: NIT-NASHs combined with FibroTest
Number of subjects: 1081
Study: 27565424

Group type: EXPERIMENTAL
Intervention: Pure water mouthwash
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Licorice mouthwash
Number of subjects: 122

Group type: COMPARATOR
Intervention: No mouthwash (control)
Number of subjects: 122
Study: 24862167

Group type: EXPERIMENTAL
Intervention: Varenicline 1 mg twice daily
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 22137672

Group type: EXPERIMENTAL
Intervention: Sevelamer (n = 47)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Calcium acetate (n = 53)
Number of subjects: 100
Study: 20638774

Group type: EXPERIMENTAL
Intervention: Global Postural Re-education (GPR)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Pelvic Floor Muscle Training (PFMT)
Number of subjects: 52
Study: 17906188

Group type: EXPERIMENTAL
Intervention: 5 days of massage therapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: 5 days without massage therapy
Number of subjects: 10
Study: 16142136

Group type: EXPERIMENTAL
Intervention: Prépidil (prostaglandin gel)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 12046339

Group type: EXPERIMENTAL
Intervention: Saliva ferning test (SFT)
Number of subjects: 70
Study: 10206605

Group type: EXPERIMENTAL
Intervention: Dynamic lumbar extension exercises with pelvic restraint
Number of subjects: 12

Group type: COMPARATOR
Intervention: Dynamic lumbar extension exercises without pelvic restraint
Number of subjects: 12
Study: 7872941

Group type: EXPERIMENTAL
Intervention: Body Dysmorphic Disorder Examination (BDDE)
Number of subjects: 0
Study: 2222274

Group type: EXPERIMENTAL
Intervention: Cryotherapy
Number of subjects: 291

Group type: COMPARATOR
Intervention: Control
Number of subjects: 291
Study: 414129

Group type: EXPERIMENTAL
Intervention: Magnesium nicotinate‐magnesium dehydrocholate
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 31439323

Group type: EXPERIMENTAL
Intervention: active tcVNS
Number of subjects: 24

Group type: COMPARATOR
Intervention: sham tcVNS
Number of subjects: 24
Study: 31815642

Group type: EXPERIMENTAL
Intervention: Social skills group training (SSGT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control groups
Number of subjects: 0
Study: 28658164

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride 0.06 mg/kg (group A)
Number of subjects: 149

Group type: EXPERIMENTAL
Intervention: Oxycodone hydrochloride 0.08 mg/kg (group B)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Fentanyl 2 ug/kg (group C)
Number of subjects: 149
Study: 25220387

Group type: COMPARATOR
Intervention: NB-UVB alone
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: NB-UVB plus calcipotriol (0.005%)
Number of subjects: 27
Study: 23681759

Group type: EXPERIMENTAL
Intervention: 60 mg/kg praziquantel
Number of subjects: 151

Group type: COMPARATOR
Intervention: 40 mg/kg praziquantel
Number of subjects: 151
Study: 21495523

Group type: EXPERIMENTAL
Intervention: Donepezil (3 mg daily)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 19629461

Group type: EXPERIMENTAL
Intervention: Grapefruit juice (GFJ) with FK506 (tacrolimus)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard FK506-based immunosuppressant regimen only (Control)
Number of subjects: 30
Study: 16958739

Group type: EXPERIMENTAL
Intervention: Natural mineral dietary supplement (NMDS), 1 l, swished twice a day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (de-ionized water), 1 l, swished twice a day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Natural mineral dietary supplement (NMDS)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (de-ionized water)
Number of subjects: 70
Study: 12864878

Group type: EXPERIMENTAL
Intervention: Perindopril treatment program
Number of subjects: 267

Group type: COMPARATOR
Intervention: Historical controls (no treatment or inconsistent treatment)
Number of subjects: 267
Study: 10695647

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT) and pharmacotherapy initiated at the outset of treatment
Number of subjects: 339

Group type: COMPARATOR
Intervention: Interpersonal psychotherapy (IPT) alone first, then combination therapy for non-remitters
Number of subjects: 339
Study: 9350017

Group type: EXPERIMENTAL
Intervention: Subcuticular suture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Staples
Number of subjects: 0
Study: 8165074

Group type: EXPERIMENTAL
Intervention: Whole cow milk
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Standard infant formula (48% to 49% of energy as fat from butterfat)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Lower fat follow-up formulas (36% kcal from a fat blend of palm olein, corn, and safflower oils)
Number of subjects: 104
Study: 3215161

Group type: EXPERIMENTAL
Intervention: Relapse-prevention (RP) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional treatment program (AA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-help formats
Number of subjects: 0

Group type: COMPARATOR
Intervention: Group-based treatment
Number of subjects: 0
Study: 30742471

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Non-trauma-focused supportive psychotherapy
Number of subjects: 117

Group type: COMPARATOR
Intervention: CPT vs Non-trauma-focused psychotherapy
Number of subjects: 117
Study: 29258724

Group type: EXPERIMENTAL
Intervention: Oral radiocontrast ingestion
Number of subjects: 20

Group type: COMPARATOR
Intervention: No oral radiocontrast (baseline)
Number of subjects: 20
Study: 23632471

Group type: EXPERIMENTAL
Intervention: Patient Participation-Based Dietary Intervention (PPDI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 56
Study: 22421690

Group type: EXPERIMENTAL
Intervention: Monthly antibiotic treatment (ciprofloxacin or azithromycin) for 9 months
Number of subjects: 636

Group type: COMPARATOR
Intervention: Placebo treatment for 9 months
Number of subjects: 636
Study: 20027030

Group type: EXPERIMENTAL
Intervention: Paracervical block with 1% lidocaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 80
Study: 18272959

Group type: EXPERIMENTAL
Intervention: Perindopril-based blood pressure lowering
Number of subjects: 1757

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1757
Study: 15745773

Group type: EXPERIMENTAL
Intervention: Pilocarpine 2%
Number of subjects: 66

Group type: COMPARATOR
Intervention: Near-point accommodation
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control IOLs
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: DCNVA
Number of subjects: 66
Study: 14519709

Group type: EXPERIMENTAL
Intervention: Azithromycin (250 mg for weight <40 kg or 500 mg for weight ≥40 kg) administered orally 3 days a week for 168 days
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo (identically packaged tablets)
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 185
Study: 10661703

Group type: EXPERIMENTAL
Intervention: Saphenous vein patch angioplasty
Number of subjects: 66
Study: 8949693

Group type: EXPERIMENTAL
Intervention: Breast milk
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Preterm formula supplemented with LCP (PF‐LCP)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Traditional preterm formula (PF)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Breast milk and PF‐LCP
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: All groups (breast milk, PF‐LCP, PF)
Number of subjects: 58
Study: 1851785

Group type: EXPERIMENTAL
Intervention: Combined potassium‐losing and ‐sparing diuretic (triamterene 50 mg plus hydrochlorothiazide 25 mg)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 7226124

Group type: EXPERIMENTAL
Intervention: CDVFP (cyclophosphamide, doxorubicin, vincristine, fluorouracil, and prednisone)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CDVFP + MER (0.4 mg S.C. every four weeks)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD/MF (CD alternating with methotrexate and fluorouracil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: CD/MF + MER (0.4 mg S.C. every four weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no immunotherapy)
Number of subjects: 0
Study: 31099929

Group type: EXPERIMENTAL
Intervention: Type 1 implant placement
Number of subjects: 46

Group type: COMPARATOR
Intervention: Type 2 implant placement
Number of subjects: 46
Study: 28577933

Group type: EXPERIMENTAL
Intervention: Selective reporting of antibiotic susceptibility test (AST) results
Number of subjects: 131

Group type: COMPARATOR
Intervention: Complete reporting of AST results
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Selective reporting of AST results
Number of subjects: 131
Study: 26438056

Group type: EXPERIMENTAL
Intervention: Movement-to-music video program (exercise every other day for 7 weeks)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 24144717

Group type: EXPERIMENTAL
Intervention: Motivational Interviews (MIs) - 5 family meetings
Number of subjects: 372

Group type: COMPARATOR
Intervention: Usual Care - information leaflet
Number of subjects: 372

Group type: EXPERIMENTAL
Intervention: Motivational Interviews (MIs)
Number of subjects: 372
Study: 21338903

Group type: EXPERIMENTAL
Intervention: Sexually active adolescents (60% of the population) reporting four or more partners
Number of subjects: 1576

Group type: EXPERIMENTAL
Intervention: Demographics, violence, and substance use correlates
Number of subjects: 1576

Group type: EXPERIMENTAL
Intervention: Dating violence
Number of subjects: 1576

Group type: EXPERIMENTAL
Intervention: Peer violence and weapon carriage
Number of subjects: 1576

Group type: EXPERIMENTAL
Intervention: Binge drinking and marijuana use
Number of subjects: 1576
Study: 19697206

Group type: EXPERIMENTAL
Intervention: Superficial injection of local anaesthetic prior to deep injection into the cervix
Number of subjects: 60

Group type: COMPARATOR
Intervention: Deep injection into the substance of the cervix (Control)
Number of subjects: 60
Study: 18389594

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (Ursosan), 3-month course of treatment
Number of subjects: 0
Study: 15244027

Group type: EXPERIMENTAL
Intervention: Female speech
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Male speech
Number of subjects: 20
Study: 11139541

Group type: EXPERIMENTAL
Intervention: Activated charcoal (5 g, four times a day, starting 3 hours after pill intake on cycle days 12, 13, and 14)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control cycle (no activated charcoal)
Number of subjects: 11
Study: 9646889

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 242

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 242

Group type: COMPARATOR
Intervention: Paroxetine
Number of subjects: 242
Study: 7994224

Group type: EXPERIMENTAL
Intervention: Treatment consisting of cleaning, depuration and motivation
Number of subjects: 82
Study: 2455442

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of 20 mg of PEP/20 ml of saline for 4 weeks
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Intravesical instillation of 40 mg of PEP/20 ml of saline for 4 weeks
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Weekly instillation of 20 mg of PEP/20 ml of saline for 8 weeks after TUR
Number of subjects: 116

Group type: COMPARATOR
Intervention: TUR alone
Number of subjects: 116
Study: 30646884

Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Training (CRT)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 65
Study: 28402515

Group type: EXPERIMENTAL
Intervention: Oxytocin (OXT)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 52
Study: 26163480

Group type: EXPERIMENTAL
Intervention: Prismatic glasses during bimanual task intervention
Number of subjects: 21

Group type: COMPARATOR
Intervention: Neutral glasses during bimanual task intervention
Number of subjects: 21
Study: 22240754

Group type: EXPERIMENTAL
Intervention: Japanese men
Number of subjects: 903

Group type: COMPARATOR
Intervention: White men
Number of subjects: 903

Group type: COMPARATOR
Intervention: Japanese-American men
Number of subjects: 903
Study: 21980001

Group type: EXPERIMENTAL
Intervention: POAG/OHT black subjects
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: POAG/OHT white subjects
Number of subjects: 91

Group type: COMPARATOR
Intervention: Healthy black controls
Number of subjects: 91

Group type: COMPARATOR
Intervention: Healthy white controls
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Black participants
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: White participants
Number of subjects: 91
Study: 18289228

Group type: EXPERIMENTAL
Intervention: Balanced salt-based high molecular weight HES solution (670/0.75)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Saline-based low molecular weight HES solution (130/0.4)
Number of subjects: 74
Study: 16691051

Group type: EXPERIMENTAL
Intervention: Tailored falls prevention exercise (16 weeks, 3 times a week, 50 min each session)
Number of subjects: 59
Study: 14763031

Group type: EXPERIMENTAL
Intervention: Tamoxifen (20 mg every 12 hours) for a mean period of 14.5 months (range: 6-30 months)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 37
Study: 11076423

Group type: EXPERIMENTAL
Intervention: Magnerot (magnesium orotate) 500 mg tablets, daily dose 3000 mg for 6 months
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 84
Study: 8955868

Group type: EXPERIMENTAL
Intervention: Astemizole-D (10 mg astemizole/240 mg pseudoephedrine)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Loratadine-D (5 mg loratadine/120 mg pseudoephedrine)
Number of subjects: 12
Study: 1550052

Group type: EXPERIMENTAL
Intervention: 15 mg manganese daily
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 60 mg iron daily
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Both mineral supplements daily
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 3912955

Group type: EXPERIMENTAL
Intervention: Coping technique treatment (10 one-hour sessions)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Waiting-list control group (no treatment initially, followed by similar treatment)
Number of subjects: 24
Study: 30048609

Group type: EXPERIMENTAL
Intervention: Triple therapy (amoxicillin, clarithromycin, and omeprazole) for 10 days
Number of subjects: 149
Study: 26481226

Group type: EXPERIMENTAL
Intervention: Endorectal multiparametric 3‐tesla MRI followed by cognitive systematic prostatic biopsy (CSPB)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Control group (no MRI)
Number of subjects: 200
Study: 24574085

Group type: EXPERIMENTAL
Intervention: Nasal saline irrigation
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32